Cargando…
Flow virometry for process monitoring of live virus vaccines-lessons learned from ERVEBO
Direct at line monitoring of live virus particles in commercial manufacturing of vaccines is challenging due to their small size. Detection of malformed or damaged virions with reduced potency is rate-limited by release potency assays with long turnaround times. Thus, preempting batch failures cause...
Autores principales: | Ricci, Geoffri, Minsker, Kevin, Kapish, Austin, Osborn, James, Ha, Sha, Davide, Joseph, Califano, Joseph P., Sehlin, Darrell, Rustandi, Richard R., Dick, Lawrence W., Vlasak, Josef, Culp, Timothy D., Baudy, Andreas, Bell, Edward, Mukherjee, Malini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016999/ https://www.ncbi.nlm.nih.gov/pubmed/33795759 http://dx.doi.org/10.1038/s41598-021-86688-z |
Ejemplares similares
-
Functional profiling of Covid 19 vaccine candidate by flow virometry
por: Prout, Ashley, et al.
Publicado: (2022) -
Development of Pandemic Vaccines: ERVEBO Case Study
por: Wolf, Jayanthi, et al.
Publicado: (2021) -
Development of process analytical tools for rapid monitoring of live virus vaccines in manufacturing
por: Yi, Sijia, et al.
Publicado: (2022) -
Flow Virometry to Analyze Antigenic Spectra of Virions and Extracellular Vesicles
por: Arakelyan, Anush, et al.
Publicado: (2017) -
Development of an imaged capillary isoelectric focusing method for characterizing the surface charge of mRNA lipid nanoparticle vaccines
por: Loughney, John W., et al.
Publicado: (2019)